VA
VANI
Methodology breakdown computing — it will appear here on its own.
Vivani Medical Inc (VANI) was screened and our screen declined to rate it, so we publish no verdict, per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for VANI — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 40.20 | NEUTRAL |
| Stochastic %K (14) | 3.64 | BUY |
| CCI (20) | -247.97 | BUY |
| Williams %R (14) | -96.36 | BUY |
| MACD (12,26,9) | -0.02 | SELL |
| ROC (10) | -10.71 | SELL |
| Momentum (10) | -0.15 | SELL |
| EMA (10) | 1.34 | SELL |
| SMA (10) | 1.36 | SELL |
| EMA (20) | 1.36 | SELL |
| SMA (20) | 1.38 | SELL |
| EMA (30) | 1.36 | SELL |
| SMA (30) | 1.38 | SELL |
| EMA (50) | 1.35 | SELL |
| SMA (50) | 1.37 | SELL |
| EMA (100) | 1.32 | SELL |
| SMA (100) | 1.30 | SELL |
| EMA (200) | 1.33 | SELL |
| SMA (200) | 1.28 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
About Vivani Medical Inc
Healthcare · Biotechnology
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Background via Yahoo Finance — informational, not part of the verdict.
Good setup, solid confluence
SMC — Top Down
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 62 |
| ⏰ 4H | BEARISH | 26 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Peer Movement
Peer movement computing — it will appear here on its own.
Insider Activity (90d)
BULLISH 2 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.